Characteristic | Mean ± SD or N (%) |
Gender Male Female |
19 (68%) 9 (32%) |
Age in years | 71 ± 10 |
Age at diagnosis of Parkinson’s disease (years) | 65 ± 11 |
Years with Parkinson’s disease | 6 ± 5 |
Body side most affected by Parkinson’s disease symptoms Right Left |
14 (50%) 14 (50%) |
Hoehn and Yahr scale Stage 1 Stage 2 Stage 3 |
10 (36%) 14 (50%) 4 (14%) |
Medications used Carbidopa/Levodopa Immediate Release Carbidopa/Levodopa Controlled Release Rasagiline Carbidopa/Levodopa Extended Release (RytaryTM) Selegiline Ropinirole |
23 (82%) 6 (21%) 4 (14%) 3 (11%) 3 (11%) 2 (7%) |
Number of Parkinson’s disease medications used per patient 1 2 3 4 |
19 (68%) 6 (21%) 2 (7%) 1 (4%) |
Levodopa equivalent dose (mg) | 486 ± 288 |